Optimization of Pitavastatin Calcium and Micronized Fenofibrate Bi-layer Tablets Using Quality by Design
1, 2, 3, 2
- 1Department of Pharmacy, Kyungsung University, Busan, SOUTH KOREA.
- 2Department of Pharmaceutical Science and Technology, Kyungsung University, Busan, SOUTH KOREA.
- 3Brain Busan Plus 21 Research Project Group, Busan, SOUTH KOREA.
CORRESPONDENCE
Prof. Kang Min Kim
Department of Pharmacy, Kyungsung University, Busan, SOUTH KOREA.
Received: 19-02-2025; Revised: 09-04-2025; Accepted: 13-06-2025.
Volume 60, Issue 1 · pp. 124-131 · 2026 · DOI: 10.5530/ijper.20260939
ABSTRACT
Background and Purpose: This study aimed to develop bilayer tablets containing pitavastatin calcium and micronized fenofibrate.Materials and Methods: For optimization of manufacturing based on preliminary formulation research, a 24+3 full factorial Design of Experiments (DoE) study was conducted to elucidate the effects of four factors (Ludipress®, crospovidone, Polyethylene Glycol (PEG) 6000, main compression) influencing tablet Critical Quality Attributes (CQAs) such as hardness, friability, assay and dissolution rates at pH 1.2 and pH 4.5 with 2.88% Sodium Lauryl Sulfate (SLS). Analysis of variance was conducted using Design Expert software to evaluate the 4 responses (hardness, friability, assay and dissolution).Results: Ludipress®(p=0.0212), crospovidone (p<0.0001), PEG 6000 (p=0.0011) and main compression (p=0.0314) significantly affected friability. Hardness was also affected by crospovidone (p=0.0208). Dissolution rates at pH 4.5 with 2.88% SLS were affected by the interaction between crospovidone and PEG 6000 (p=0.0417). These results indicate that the optimized ranges of Ludipress® (4.55-10.59%), crospovidone (7.36-8.94%), PEG 6000 (8.06-9.09%) and main compression (1903-2158.41 kgf) had a positive influence on the tablet CQAs.Conclusion: Process optimization of the bilayer tablets was conducted using a four-factor, two-level, full-factorial design. This enabled the rapid evaluation and identification of critical process variables, facilitating the successful evaluation of bilayer tablets with excellent quality using the quality by design approach.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Park, J. W., Song, I. D., Kang, J. S., & Kim, K. M. (2026). Optimization of Pitavastatin Calcium and Micronized Fenofibrate Bi-layer Tablets Using Quality by Design. Indian Journal of Pharmaceutical Education and Research, 60(1), 124-131. https://doi.org/10.5530/ijper.20260939
Copyright and licence
© 2026 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0
